Exane Derivatives’s AvalonBay Communities AVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-721
Closed -$179K 790
2022
Q1
$179K Buy
721
+720
+72,000% +$176K 0.05% 363
2021
Q4
$253 Hold
1
﹤0.01% 823
2021
Q3
$222 Hold
1
﹤0.01% 1006
2021
Q2
$221 Buy
+1
New +$200 ﹤0.01% 1011
2021
Q1
Sell
-15
Closed -$2.41K 911
2020
Q4
$2.41K Hold
15
﹤0.01% 611
2020
Q3
$2.24K Hold
15
﹤0.01% 554
2020
Q2
$2.32K Hold
15
﹤0.01% 495
2020
Q1
$2.21K Hold
15
﹤0.01% 492
2019
Q4
$3.18K Hold
15
﹤0.01% 464
2019
Q3
$3.23K Sell
15
-8
-35% -$1.67K ﹤0.01% 465
2019
Q2
$4.67K Buy
+23
New +$4.66K ﹤0.01% 478
2019
Q1
Sell
-1,098
Closed -$191K 660
2018
Q4
$191K Sell
1,098
-428
-28% -$77.3K 0.03% 252
2018
Q3
$276K Buy
1,526
+1,523
+50,767% +$272K 0.05% 218
2018
Q2
$518 Hold
3
﹤0.01% 565
2018
Q1
$488 Sell
3
-2,428
-100% -$398K ﹤0.01% 508
2017
Q4
$434K Buy
+2,431
New +$441K 0.07% 180
2017
Q3
Sell
-3,389
Closed -$651K 575
2017
Q2
$651K Buy
+3,389
New +$648K 0.14% 119
2016
Q3
Sell
-1
Closed -$180 631
2016
Q2
$180 Sell
1
-248
-100% -$44.7K ﹤0.01% 451
2016
Q1
$47.4K Buy
+249
New +$44K 0.01% 320

Other funds holding AVB

Exane Derivatives's AVB Position: Q2 2022 in Review

Exane Derivatives sold out of AvalonBay Communities (AVB) in Q2 2022, closing a stake of 721 shares — an estimated $179K sold.

Exane Derivatives first reported a position in AVB in Q1 2016 and held it in 19 quarters. The position peaked at $651K in Q2 2017. 629 funds tracked by Wall St. Rank hold AVB as of Q2 2022.

  • Exane Derivatives reported no remaining AvalonBay Communities position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 721 AvalonBay Communities shares in Q2 2022, an estimated $179K.
  • Exane Derivatives first reported a position in AvalonBay Communities in Q1 2016 and held it in 19 quarters.
  • Exane Derivatives's AvalonBay Communities position peaked at $651K in Q2 2017.
  • 629 funds tracked by Wall St. Rank held AvalonBay Communities as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.